💰180 Life Sciences plans to raise $425 million through a private placement to establish an ETH treasury. NASDAQ-listed company 180 Life Sciences announced plans to raise approximately $425 million through private equity financing, with the funds intended to support the establishment of an Ethereum treasury. After the transaction is completed, the company will be renamed ETHZilla Corporation. Reportedly, the transaction's investors include Harbour Island, Electric Capital, Polychain Capital, GSR, Omicron Technologies, Konstantin Lomashuk (co-founder of Lido and p2), Sreeram Kannan (founder of Eigenlayer), Mike Silagadze (founder), Danny Ryan (co-founder of Etherealize), Vivek Raman (co-founder of Etherealize), Sam Kazemanian (co-founder of Frax), Grant Hummer (co-founder of Etherealize), Robert Leshner (founder of Compound and Superstate), Tarun Chitra (founder of Gauntlet), among others.
Show original
7.61K
0
The content on this page is provided by third parties. Unless otherwise stated, OKX is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.